Reply to Comment on "Market Exclusivity for Drugs with Multiple Orphan Approvals (1983-2017) and Associated Budget Impact in the US".

Szczegóły
Comments

Tytuł:: Reply to Comment on "Market Exclusivity for Drugs with Multiple Orphan Approvals (1983-2017) and Associated Budget Impact in the US".
Autorzy:: Padula WV; Department of Pharmaceutical and Health Economics, School of Pharmacy, USC Schaeffer Center, University of Southern California, 635 Downey Way, Los Angeles, CA, 90089, USA. .; Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles, CA, USA. .
Parasrampuria S; Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Socal MP; Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Conti RM; Institute for Health System Innovation and Policy, Boston University Questrom School of Business, Boston, MA, USA.
Anderson GF; Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Źródło:: PharmacoEconomics [Pharmacoeconomics] 2020 Dec; Vol. 38 (12), pp. 1375-1376. Date of Electronic Publication: 2020 Nov 09.
Typ publikacji:: Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Comment
Język:: English
Imprint Name(s):: Publication: Auckland : Adis, Springer International
Original Publication: Auckland ; Philadelphia : Adis International, c1992-
MeSH Terms:: Orphan Drug Production*
Pharmaceutical Preparations*
Budgets ; Humans ; Rare Diseases
References:: Pharmacoeconomics. 2020 Dec;38(12):1375-1376. (PMID: 33164137)
Value Health. 2020 Nov;23(11):1470-1476. (PMID: 33127018)
Biostatistics. 2019 Apr 1;20(2):273-286. (PMID: 29394327)
Pharmacoeconomics. 2020 Oct;38(10):1115-1121. (PMID: 32533523)
JAMA. 2017 Jun 6;317(21):2163-2164. (PMID: 28459924)
Grant Information:: KL2 TR001854 United States TR NCATS NIH HHS
Substance Nomenclature:: 0 (Pharmaceutical Preparations)
Entry Date(s):: Date Created: 20201109 Date Completed: 20201216 Latest Revision: 20240330
Update Code:: 20240330
PubMed Central ID:: PMC7721406
DOI:: 10.1007/s40273-020-00973-9
PMID:: 33164137
: Raport

Full Text Finder

Comment on: Pharmacoeconomics. 2020 Oct;38(10):1115-1121. (PMID: 32533523)
Comment on: Pharmacoeconomics. 2020 Dec;38(12):1373-1374. (PMID: 33164138)

Informacja